United States · FDA National Drug Code directory
Canasa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58914-501_f6634219-3e94-4856-b896-67c3bd3b168d
- Product NDC
- 58914-501
- Form
- SUPPOSITORY
- Composition / generic term
- Mesalamine
- Labeler
- Allergan, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20010105
- Source listing expiry
- 20271231
Source-listed ingredients
- MESALAMINE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 SUPPOSITORY in 1 BOX (58914-501-33) · 58914-501-33
- 42 SUPPOSITORY in 1 BOX (58914-501-42) · 58914-501-42
- 30 SUPPOSITORY in 1 BOX (58914-501-56) · 58914-501-56
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →